Nick Devoogdt
-
- Monoclonal and Polyclonal Antibodies Research 99
- Radiopharmaceutical Chemistry and Applications 52
- Immunology top 1%
- Immunotherapy and Immune Responses 22
- Oncology top 0.5%
- HER2/EGFR in Cancer Research 24
- CAR-T cell therapy research 19
- Cancer Immunotherapy and Biomarkers 19
- Peptidase Inhibition and Analysis 18
- Molecular Biology top 2%
- Glycosylation and Glycoproteins Research 19
- Biomaterials top 2%
- Co-authors
- Tony LahoutteSerge MuyldermansVicky CaveliersCatarina XavierGeert RaesMatthias D’HuyvetterMarleen KeyaertsCécile Vincke
- Journals
- Journal of Nuclear Medicine (16 papers)Molecular Imaging and Biology (8 papers)Frontiers in Immunology (6 papers)
- Partner nations
- BelgiumFranceUnited States
In The Last Decade
Nick Devoogdt
151 papers receiving 8.1k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Radiology, Nuclear Medicine and Imaging 5.1k
- Immunology 2.1k
- Oncology 2.7k
- Molecular Biology 3.3k
- Biomaterials 469
Countries citing papers authored by Nick Devoogdt
This map shows the geographic impact of Nick Devoogdt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nick Devoogdt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nick Devoogdt more than expected).
Fields of papers citing papers by Nick Devoogdt
This network shows the impact of papers produced by Nick Devoogdt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nick Devoogdt. The network helps show where Nick Devoogdt may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nick Devoogdt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 9 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 7 | |
| 6 | 2024 | 4 | |
| 7 | 2023 | 19 | |
| 8 | 2023 | 5 | |
| 9 | 2021 | 27 | |
| 10 | 2021 | 9 | |
| 11 | 2017 | 55 | |
| 12 | 2017 | 141 | |
| 13 | 2017 | 40 | |
| 14 | 2017 | 60 | |
| 15 | 2016 | 100 | |
| 16 | 2014 | 79 | |
| 17 | 2012 | 244 | |
| 18 | 2012 | 91 | |
| 19 | Nanobody-coupled microbubbles as novel molecular tracer. | 2012 | 1 |
| 20 | 2010 | 109 |
About Nick Devoogdt
Nick Devoogdt is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Immunology, having authored 155 papers that have together received 8.2k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (99 papers), Radiopharmaceutical Chemistry and Applications (52 papers), HER2/EGFR in Cancer Research (24 papers), Immunotherapy and Immune Responses (22 papers), Glycosylation and Glycoproteins Research (19 papers), CAR-T cell therapy research (19 papers), Cancer Immunotherapy and Biomarkers (19 papers) and Peptidase Inhibition and Analysis (18 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (5.1k citations), Immunology (2.1k citations) and Oncology (2.7k citations). Nick Devoogdt has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include Tony Lahoutte, Serge Muyldermans, Vicky Caveliers, Catarina Xavier, Geert Raes, Matthias D’Huyvetter, Marleen Keyaerts, Cécile Vincke, Patrick De Baetselier and Karine Breckpot. Their work appears in journals such as Journal of Nuclear Medicine, Molecular Imaging and Biology, Frontiers in Immunology, Theranostics and Biomolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.